Alnylam Pharmaceuticals
ALNY
#661
Rank
NZ$51.90 B
Marketcap
$402.40
Share price
-8.43%
Change (1 day)
42.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company